Real-World Efficacy and Safety of Lenvatinib in Korean Patients with Advanced Hepatocellular Carcinoma: A Multicenter Retrospective Analysis

Introduction/Objective: Lenvatinib demonstrated efficacy and safety in patients with advanced hepatocellular carcinoma (HCC) in the randomized phase III REFLECT trial. Considering the discrepancies in patients between clinical trial data and daily practice, an account of practical experience is need...

Full description

Bibliographic Details
Main Authors: Jaekyung Cheon, Hong Jae Chon, Yeonghak Bang, Neung Hwa Park, Jung Woo Shin, Kang Mo Kim, Han Chu Lee, Jooho Lee, Changhoon Yoo, Baek-Yeol Ryoo
Format: Article
Language:English
Published: Karger Publishers 2020-07-01
Series:Liver Cancer
Subjects:
Online Access:https://www.karger.com/Article/FullText/508901